As such, ZBP-89 has been shown to induce cellular senescence when overexpressed in lung cancer cells due to its ability to recruit HDACs to the cyclin-dependent inhibitor p16INK4A promoter [6]. Here, CDKN2C is linked to lung carcinoma.